Embracing Future Holdings Limited (SGX:8YY)

Market Cap	78.00M +130.7%
Revenue (ttm)	5.26M +513.2%
Net Income	-3.96M
EPS	-0.00
Shares Out	1.73B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,717,300
Average Volume	2,465,245
Open	0.0480
Previous Close	0.0450
Day's Range	0.0460 - 0.0480
52-Week Range	0.0200 - 0.0920
Beta	n/a
RSI	36.48
Earnings Date	May 20, 2026

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 b...

• Founded: 2009
• Employees: 16
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 8YY

Financial Performance

In 2025, Embracing Future Holdings's revenue was 5.26 million, an increase of 513.17% compared to the previous year's 858,000. Losses were -3.96 million, 15.4% more than in 2024.